Dov Shiffman

This inventor holds 12 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 11 EPO patents, primarily in Genetic Polymorphisms. Top assignees: Celera Corporation, Quest Diagnostics Investments, Inc., The Brigham and Women's Hospital, Inc.. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dov Shiffman. Retrieved from https://idiyas.com/inventor/dov-shiffman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 5

EPO Patents = 11 (Patent Applications = 12)

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 19(Granted Patents)

Company Filing History:

Quest Diagnostics Investments, Inc.

patents

3 out of 1,430

The Brigham and Women's Hospital, Inc.

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

Insulin Quantitation

C-Peptide Measurement

Genetic Polymorphisms

Cardiovascular Diseases

Statin Response

Apo(a) Gene

Coronary Heart Disease

Detection Methods

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12332236 - Methods for quantitation of insulin and C-peptide (2025-06-17),

2. 12025610 - Methods for quantitation of insulin and C-peptide (2024-07-02),

3. 11827937 - Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof (2023-11-28),

4. 11697850 - Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment (2023-07-11),

5. 11408034 - Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof (2022-08-09),

6. 10983108 - Methods for quantitation of insulin and C-peptide (2021-04-20),

7. 10584384 - Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof (2020-03-10),

8. 10563263 - Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof (2020-02-18),

9. 10550433 - Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment (2020-02-04),

10. 8216786 - Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof (2012-07-10),

11. 7977052 - Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof (2011-07-12),

12. 7943317 - Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment (2011-05-17),

Title: The Innovative Journey of Dov Shiffman

Introduction: Dov Shiffman, a pioneering inventor based in Palo Alto, CA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions and patents.

Latest Patents: Dov Shiffman holds several patents in the field of artificial intelligence and machine learning, with his most recent patent focusing on a revolutionary algorithm for predictive analytics in healthcare.

Career Highlights: With a background in computer science and engineering, Dov Shiffman has had a distinguished career working for leading tech companies in Silicon Valley, where he has spearheaded projects that have pushed the boundaries of technological advancement.

Collaborations: Throughout his career, Dov Shiffman has collaborated with top researchers and scientists from renowned universities and research institutions, fostering a culture of innovation and knowledge sharing in the tech industry.

Conclusion: Dov Shiffman's relentless pursuit of innovation and his passion for creating cutting-edge solutions have solidified his reputation as a visionary inventor in the ever-evolving landscape of technology.

Profile summary based on public USPTO records.